How many drugs treat Postabortal Hemorrhage?

Drug Landscape tracks 3 marketed treatments for Postabortal Hemorrhage (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/postabortal-hemorrhage.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Postabortal Hemorrhage — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Postabortal Hemorrhage (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Postabortal Hemorrhage, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Methergine	methylergometrine	Edison Theraps Llc	Ergot Derivative	5-hydroxytryptamine receptor 2A	1946-01-01
Ergobasine	Ergometrine	Cairo University	ergometrine	5-hydroxytryptamine receptor 1D
Methergine	Methergine	University of South Florida		5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 6, 5-hydroxytryptamine receptor 1A

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Cairo University · 1 drug in Postabortal Hemorrhage
Edison Theraps Llc · 1 drug in Postabortal Hemorrhage
University of South Florida · 1 drug in Postabortal Hemorrhage

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Postabortal Hemorrhage:

Cite this brief

Drug Landscape (2026). Postabortal Hemorrhage — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/postabortal-hemorrhage. Accessed 2026-06-10.

Postabortal Hemorrhage full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing